SERA PROGNOSTICS, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $41.00K, a 4000.00% increase year-over-year.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $22.00K, a 53.19% decline year-over-year.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $393.00K, a 72.37% increase year-over-year.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $1.00K, a 99.92% decline year-over-year.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $507.00K, a 82.53% decline from fiscal 2024.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $2.90M, a 165.02% increase from fiscal 2023.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $1.09M, a 255.52% increase from fiscal 2022.
- SERA PROGNOSTICS, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $308.00K, a 47.97% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $41.00K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $22.00K 10-Q · filed 2026-08-12 | |
| 2025-12-31 | $507.00K 10-K · filed 2026-03-18 | |
| 2025-09-30 | $393.00K 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $1.00K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | $47.00K 10-Q · filed 2026-08-12 | |
| 2024-12-31 | $2.90M 10-K · filed 2026-03-18 | |
| 2024-09-30 | $228.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.26M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $1.16M 10-Q · filed 2025-11-13 | |
| 2023-12-31 | $1.09M 10-K · filed 2025-03-19 | |
| 2023-09-30 | $244.00K 10-Q · filed 2024-11-06 | |
| 2023-06-30 | $178.00K 10-Q · filed 2024-11-06 | |
| 2023-03-31 | $4.00K 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $308.00K 10-K · filed 2024-03-20 | |
| 2022-09-30 | $39.00K 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $170.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $98.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $592.00K 10-K · filed 2023-03-22 | |
| 2021-09-30 | $273.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $35.00K 10-Q · filed 2022-11-09 | |
| 2021-03-31 | $229.00K 10-Q · filed 2022-11-09 | |
| 2020-12-31 | $176.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $78.00K 10-Q · filed 2021-11-09 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |